LT3348258T - Per burną vartojamos ir injekuojamos tetraciklino junginių kompozicijos - Google Patents

Per burną vartojamos ir injekuojamos tetraciklino junginių kompozicijos

Info

Publication number: LT3348258T
Authority: LT; Lithuania
Prior art keywords: oral; injectable formulations; tetracycline compounds; tetracycline; compounds
Prior art date: 2008-03-28

Application number

LTEP18158017.6T

Other languages

English (en)

Inventor

Sean Johnston

Original Assignee

Paratek Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-28

Filing date

2009-03-30

Publication date

2020-12-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41114256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3348258(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-03-30 Application filed by Paratek Pharmaceuticals, Inc. filed Critical Paratek Pharmaceuticals, Inc.

2020-12-10 Publication of LT3348258T publication Critical patent/LT3348258T/lt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Biophysics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

LTEP18158017.6T 2008-03-28 2009-03-30 Per burną vartojamos ir injekuojamos tetraciklino junginių kompozicijos LT3348258T (lt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US4039808P	2008-03-28	2008-03-28

Publications (1)

Publication Number	Publication Date
LT3348258T true LT3348258T (lt)	2020-12-10

Family

ID=41114256

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
LTEP09723896.8T LT2271348T (lt)	2008-03-28	2009-03-30	Tetraciklino junginio geriamosios tabletės kompozicija
LTEP18158017.6T LT3348258T (lt)	2008-03-28	2009-03-30	Per burną vartojamos ir injekuojamos tetraciklino junginių kompozicijos

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
LTEP09723896.8T LT2271348T (lt)	2008-03-28	2009-03-30	Tetraciklino junginio geriamosios tabletės kompozicija

Country Status (30)

Country	Link
US (2)	US9314475B2 (lt)
EP (3)	EP2271348B1 (lt)
JP (8)	JP2011515473A (lt)
KR (3)	KR101893740B1 (lt)
CN (1)	CN102046177B (lt)
AU (1)	AU2009229174A1 (lt)
BR (2)	BRPI0909211B8 (lt)
CA (2)	CA2719751C (lt)
CL (1)	CL2010000281A1 (lt)
CO (1)	CO6300935A2 (lt)
CY (2)	CY1120240T1 (lt)
DK (2)	DK2271348T3 (lt)
EC (1)	ECSP10010576A (lt)
ES (2)	ES2836448T3 (lt)
HR (2)	HRP20180836T1 (lt)
HU (2)	HUE038257T2 (lt)
IL (1)	IL208440A0 (lt)
LT (2)	LT2271348T (lt)
MA (1)	MA32275B1 (lt)
MX (1)	MX2010010585A (lt)
NO (1)	NO2271348T3 (lt)
NZ (1)	NZ588428A (lt)
PL (2)	PL2271348T3 (lt)
PT (2)	PT2271348T (lt)
RU (1)	RU2010144130A (lt)
SI (2)	SI2271348T1 (lt)
TR (1)	TR201806893T4 (lt)
UA (2)	UA122762C2 (lt)
WO (1)	WO2009120389A1 (lt)
ZA (1)	ZA201007013B (lt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2717703A1 (en)	2008-03-05	2009-09-11	Paratek Pharmaceuticals, Inc.	Minocycline compounds and methods of use thereof
TW202216656A (zh)	2008-05-19	2022-05-01	美商ＰｒｔｋＳｐｖ２公司	四環素化合物之甲苯磺酸鹽及同素異形體
KR101799304B1 (ko)	2010-05-12	2017-11-20	렘펙스 파머수티클스 인코퍼레이티드	테트라사이클린 조성물
US10238670B2 (en) *	2016-05-02	2019-03-26	Paratek Pharmaceuticals, Inc.	9-aminomethyl minocycline compounds and methods of use thereof in urinary tract infection (UTI) treatment
US10166912B2 (en)	2016-08-19	2019-01-01	Sl Corporation	Automotive LED driving apparatus
RU2019113715A (ru)	2016-11-01	2020-12-03	Паратек Фармасьютикалс, Инк.	9-аминометилминоциклиновые соединения и их применение для лечениия внебольничной бактериальной пневмонии(вбп)
BR112021004057A2 (pt) *	2018-09-04	2021-05-25	Paratek Pharmaceuticals, Inc.	métodos de tratar ou prevenir uma infecção micobacteriana, de tratar ou prevenir, de controlar ou reduzir o avanço, severidade ou efeitos de uma doença micobacteriana, tuberculose, lepra, bronquiectasia, doença pulmonar cavitária, linfadenite, uma doença de tecido mole, granuloma de aquário, úlcera de buruli, uma doença ocular e doença óssea em um indivíduo em necessidade dos mesmos, e, métodos de tratar um indivíduo com uma doença pulmonar e de tratar um indivíduo com uma condição imunossuprimida.
AU2020419197B2 (en) *	2019-12-30	2023-08-31	Deciphera Pharmaceuticals, Llc	Amorphous kinase inhibitor formulations and methods of use thereof
PT117254B (pt)	2021-05-26	2024-04-18	Hovione Farm S A	Método de síntese de compostos 9-aminometil tetraciclinas

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2699054A (en) *	1953-10-09	1955-01-11	Lloyd H Conover	Tetracycline
US2712517A (en) *	1954-03-03	1955-07-05	Bristol Lab Inc	Production of tetracycline and substituted tetracyclines
US3019173A (en) *	1956-06-04	1962-01-30	American Cyanamid Co	Method for preparing tetracycline
US2990331A (en)	1956-11-23	1961-06-27	Pfizer & Co C	Stable solutions of salts of tetracyclines for parenteral administration
US3005023A (en) *	1957-04-05	1961-10-17	American Cyanamid Co	Production of tetracycline
US2980584A (en)	1957-10-29	1961-04-18	Pfizer & Co C	Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US2886595A (en) *	1958-09-30	1959-05-12	Bristol Lab Inc	Tetracycline recovery
US3062717A (en)	1958-12-11	1962-11-06	Pfizer & Co C	Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3019260A (en) *	1959-05-13	1962-01-30	American Cyanamid Co	Process for the catalytic reduction of 6-hydroxy hydronaphthacenes
FR1430859A (lt) *	1960-05-23	1966-05-25
US3165531A (en)	1962-03-08	1965-01-12	Pfizer & Co C	13-substituted-6-deoxytetracyclines and process utilizing the same
US3301899A (en) *	1963-11-27	1967-01-31	Bristol Myers Co	Purification of tetracycline
US3454697A (en)	1965-06-08	1969-07-08	American Cyanamid Co	Tetracycline antibiotic compositions for oral use
NL6607516A (lt)	1966-05-31	1967-12-01
DE1767891C3 (de)	1968-06-28	1980-10-30	Pfizer	Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en)	1972-10-26	1976-05-18	Pfizer Inc.	Doxycycline parenteral compositions
DE2442829A1 (de)	1974-09-06	1976-03-18	Merck Patent Gmbh	Tetracyclische verbindungen und verfahren zu ihrer herstellung
US4018889A (en)	1976-01-02	1977-04-19	Pfizer Inc.	Oxytetracycline compositions
US4126680A (en)	1977-04-27	1978-11-21	Pfizer Inc.	Tetracycline antibiotic compositions
US4837030A (en)	1987-10-06	1989-06-06	American Cyanamid Company	Novel controlled release formulations of tetracycline compounds
DE122006000058I2 (de)	1991-10-04	2007-09-13	Wyeth Corp	7-Substituierte-9-substituierte Amino-6-Demethyl-6-Deoxy-Tetracycline
US5494903A (en) *	1991-10-04	1996-02-27	American Cyanamid Company	7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US6465431B1 (en) *	1999-11-17	2002-10-15	Boston Life Sciences, Inc.	Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
TR200000529T2 (tr)	1997-08-29	2000-08-21	Dsm N.V.	İçinde eksipiyan olmayan granüller
KR100252699B1 (ko) *	1998-03-17	2000-12-01	강재헌	치주염 치료용 미노사이클린 조성물
DE69932846T2 (de)	1998-11-18	2007-03-15	Collagenex Pharmaceuticals, Inc.	Neue 4-dedimethylaminotetracyclinderivate
US6448323B1 (en)	1999-07-09	2002-09-10	Bpsi Holdings, Inc.	Film coatings and film coating compositions based on polyvinyl alcohol
JP4516711B2 (ja) *	1999-12-28	2010-08-04	中外製薬株式会社	安定な抗体組成物及び注射製剤
EA201000496A1 (ru) *	2000-07-07	2010-10-29	Трастис Оф Тафтс Коллидж	Замещенное соединение миноциклина, способ получения замещенных соединений миноциклина (варианты)
HRP20030743A2 (en)	2001-03-13	2005-06-30	Paratek Pharmaceuticals	7,9-substituted tetracycline compounds
US7553828B2 (en) *	2001-03-13	2009-06-30	Paratek Pharmaceuticals, Inc.	9-aminomethyl substituted minocycline compounds
US7045507B2 (en) *	2001-03-14	2006-05-16	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds as synergistic antifungal agents
WO2002083106A1 (en) *	2001-04-05	2002-10-24	Collagenex Pharmaceuticals, Inc.	Controlled delivery of tetracycline compounds and tetracycline derivatives
US8088820B2 (en) *	2001-04-24	2012-01-03	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds for the treatment of malaria
EP2332549A1 (en) *	2001-07-13	2011-06-15	Paratek Pharmaceuticals, Inc.	Novel tetracyclines and their use in medicine
EP2316450A1 (en)	2002-03-08	2011-05-04	Paratek Pharmaceuticals, Inc.	Amino-methyl substituted tetracycline compounds
CN1390550A (zh) *	2002-07-25	2003-01-15	于航	盐酸米诺环素冻干粉针剂及其制备方法
JP2006503898A (ja) *	2002-10-24	2006-02-02	パラテックファーマシューティカルズ，インク．	マラリア治療のための置換テトラサイクリン化合物
US8173624B2 (en) *	2002-10-24	2012-05-08	Paratek Pharmaceuticals, Inc.	Methods of using substituted tetracycline compounds to modulate RNA
US20040121003A1 (en) *	2002-12-19	2004-06-24	Acusphere, Inc.	Methods for making pharmaceutical formulations comprising deagglomerated microparticles
WO2004064728A2 (en) *	2003-01-16	2004-08-05	Paratek Pharmaceuticals, Inc.	Use of specific tetracycline compounds in therapy
WO2004069224A2 (en) *	2003-02-03	2004-08-19	Neopharm, Inc.	Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs
WO2004078111A2 (en) *	2003-03-06	2004-09-16	Ranbaxy Laboratories Limited	Extended release minocycline compositions and processes for their preparation
WO2004091513A2 (en) *	2003-04-10	2004-10-28	Paratek Pharmaceuticals, Inc.	9-aminomethyl substituted minocycline compounds
US20060287283A1 (en) *	2003-07-09	2006-12-21	Paratek Pharmaceuticals, Inc.	Prodrugs of 9-aminomethyl tetracycline compounds
CN1845897A (zh) *	2003-07-09	2006-10-11	帕拉特克药品公司	取代的四环素化合物
EP1656341A1 (en) *	2003-07-09	2006-05-17	Paratek Pharmaceuticals, Inc.	Prodrugs of 9-aminomethyl tetracycline compounds
EP2332904A3 (en) *	2004-01-15	2012-04-11	Paratek Pharmaceuticals, Inc.	Derivatives of tetracycline compounds
GB2414668B (en) *	2004-06-03	2009-07-29	Dexcel Ltd	Tetracycline modified release delivery system
PE20061107A1 (es) *	2005-03-14	2006-12-08	Wyeth Corp	Composiciones de tigeciclina y metodos para su preparacion
WO2007087416A2 (en)	2006-01-24	2007-08-02	Paratek Pharaceuticals, Inc.	Methods of increasing oral bioavailability of tetracyclines
US20090246276A1 (en) *	2008-01-28	2009-10-01	Graham Jackson	Pharmaceutical Compositions
CA2717703A1 (en) *	2008-03-05	2009-09-11	Paratek Pharmaceuticals, Inc.	Minocycline compounds and methods of use thereof

2009
- 2009-03-03 PT PT97238968T patent/PT2271348T/pt unknown
- 2009-03-30 NZ NZ588428A patent/NZ588428A/xx not_active IP Right Cessation
- 2009-03-30 HU HUE09723896A patent/HUE038257T2/hu unknown
- 2009-03-30 UA UAA201505310A patent/UA122762C2/uk unknown
- 2009-03-30 DK DK09723896.8T patent/DK2271348T3/en active
- 2009-03-30 KR KR1020187005923A patent/KR101893740B1/ko active Active
- 2009-03-30 CA CA2719751A patent/CA2719751C/en active Active
- 2009-03-30 DK DK18158017.6T patent/DK3348258T3/da active
- 2009-03-30 MX MX2010010585A patent/MX2010010585A/es not_active Application Discontinuation
- 2009-03-30 SI SI200931826T patent/SI2271348T1/en unknown
- 2009-03-30 RU RU2010144130/15A patent/RU2010144130A/ru not_active Application Discontinuation
- 2009-03-30 SI SI200932097T patent/SI3348258T1/sl unknown
- 2009-03-30 UA UAA201012435A patent/UA109627C2/ru unknown
- 2009-03-30 HR HRP20180836TT patent/HRP20180836T1/hr unknown
- 2009-03-30 WO PCT/US2009/001973 patent/WO2009120389A1/en not_active Ceased
- 2009-03-30 TR TR2018/06893T patent/TR201806893T4/tr unknown
- 2009-03-30 EP EP09723896.8A patent/EP2271348B1/en active Active
- 2009-03-30 CA CA2984301A patent/CA2984301C/en active Active
- 2009-03-30 LT LTEP09723896.8T patent/LT2271348T/lt unknown
- 2009-03-30 BR BRPI0909211A patent/BRPI0909211B8/pt active IP Right Grant
- 2009-03-30 LT LTEP18158017.6T patent/LT3348258T/lt unknown
- 2009-03-30 KR KR1020167023203A patent/KR101835574B1/ko active Active
- 2009-03-30 PT PT181580176T patent/PT3348258T/pt unknown
- 2009-03-30 PL PL09723896T patent/PL2271348T3/pl unknown
- 2009-03-30 ES ES18158017T patent/ES2836448T3/es active Active
- 2009-03-30 AU AU2009229174A patent/AU2009229174A1/en not_active Abandoned
- 2009-03-30 ES ES09723896.8T patent/ES2674708T3/es active Active
- 2009-03-30 KR KR1020107024076A patent/KR101746228B1/ko active Active
- 2009-03-30 JP JP2011501848A patent/JP2011515473A/ja active Pending
- 2009-03-30 BR BR122020011180A patent/BR122020011180B8/pt active IP Right Grant
- 2009-03-30 PL PL18158017T patent/PL3348258T3/pl unknown
- 2009-03-30 NO NO09723896A patent/NO2271348T3/no unknown
- 2009-03-30 US US12/414,615 patent/US9314475B2/en active Active
- 2009-03-30 HU HUE18158017A patent/HUE052201T2/hu unknown
- 2009-03-30 EP EP18158017.6A patent/EP3348258B1/en active Active
- 2009-03-30 CN CN2009801191056A patent/CN102046177B/zh not_active Ceased
- 2009-03-30 EP EP20189488.8A patent/EP3789030A1/en active Pending
2010
- 2010-03-29 CL CL2010000281A patent/CL2010000281A1/es unknown
- 2010-10-01 ZA ZA2010/07013A patent/ZA201007013B/en unknown
- 2010-10-03 IL IL208440A patent/IL208440A0/en unknown
- 2010-10-25 MA MA33281A patent/MA32275B1/fr unknown
- 2010-10-26 CO CO10132833A patent/CO6300935A2/es not_active Application Discontinuation
- 2010-10-27 EC EC2010010576A patent/ECSP10010576A/es unknown
2014
- 2014-07-28 JP JP2014152471A patent/JP5940119B2/ja active Active
2016
- 2016-03-07 US US15/062,499 patent/US20160279151A1/en not_active Abandoned
- 2016-05-17 JP JP2016098578A patent/JP6412521B2/ja active Active
2018
- 2018-05-23 CY CY20181100542T patent/CY1120240T1/el unknown
- 2018-09-28 JP JP2018183953A patent/JP6577645B2/ja active Active
2019
- 2019-08-22 JP JP2019151857A patent/JP2019196408A/ja active Pending
2020
- 2020-09-24 CY CY20201100908T patent/CY1123382T1/el unknown
- 2020-11-26 HR HRP20201883TT patent/HRP20201883T1/hr unknown
2021
- 2021-07-28 JP JP2021122850A patent/JP2021167355A/ja active Pending
2023
- 2023-08-16 JP JP2023132396A patent/JP2023144043A/ja active Pending
2025
- 2025-07-23 JP JP2025123003A patent/JP2025137721A/ja active Pending

Also Published As

Publication number	Publication date
ES2674708T3 (es)	2018-07-03
MX2010010585A (es)	2010-11-09
NZ588428A (en)	2012-08-31
HUE052201T2 (hu)	2021-04-28
WO2009120389A1 (en)	2009-10-01
CY1120240T1 (el)	2019-07-10
KR20180026799A (ko)	2018-03-13
KR101746228B1 (ko)	2017-06-12
EP3348258B1 (en)	2020-09-09
CA2984301C (en)	2020-10-27
US20160279151A1 (en)	2016-09-29
MA32275B1 (fr)	2011-05-02
US9314475B2 (en)	2016-04-19
JP2025137721A (ja)	2025-09-19
EP2271348A1 (en)	2011-01-12
JP2018203778A (ja)	2018-12-27
JP2021167355A (ja)	2021-10-21
IL208440A0 (en)	2010-12-30
SI3348258T1 (sl)	2020-12-31
CY1123382T1 (el)	2021-12-31
PL2271348T3 (pl)	2018-08-31
NO2271348T3 (lt)	2018-08-25
CA2719751A1 (en)	2009-10-01
BR122020011180B1 (pt)	2021-03-23
KR101893740B1 (ko)	2018-08-30
BRPI0909211A2 (pt)	2016-11-29
HUE038257T2 (hu)	2018-10-29
BRPI0909211B1 (pt)	2020-08-25
ZA201007013B (en)	2013-11-27
BR122020011180B8 (pt)	2021-07-27
BRPI0909211B8 (pt)	2021-05-25
ES2836448T3 (es)	2021-06-25
US20100056638A1 (en)	2010-03-04
EP3348258A1 (en)	2018-07-18
JP6577645B2 (ja)	2019-09-18
HK1257928A1 (en)	2019-11-01
DK2271348T3 (en)	2018-06-14
CN102046177B (zh)	2012-12-19
PT2271348T (pt)	2018-04-16
EP2271348A4 (en)	2011-05-25
JP2019196408A (ja)	2019-11-14
HRP20201883T1 (hr)	2021-01-22
JP2016145260A (ja)	2016-08-12
RU2010144130A (ru)	2012-05-10
UA122762C2 (uk)	2021-01-06
CA2719751C (en)	2018-01-02
UA109627C2 (uk)	2015-09-25
EP3789030A1 (en)	2021-03-10
KR101835574B1 (ko)	2018-03-08
TR201806893T4 (tr)	2018-06-21
JP6412521B2 (ja)	2018-10-24
PL3348258T3 (pl)	2021-03-08
CL2010000281A1 (es)	2012-03-30
KR20160105532A (ko)	2016-09-06
EP2271348B1 (en)	2018-03-28
CO6300935A2 (es)	2011-07-21
CN102046177A (zh)	2011-05-04
SI2271348T1 (en)	2018-08-31
JP2023144043A (ja)	2023-10-06
DK3348258T3 (da)	2020-12-07
AU2009229174A1 (en)	2009-10-01
CA2984301A1 (en)	2009-10-01
JP2011515473A (ja)	2011-05-19
ECSP10010576A (es)	2010-12-30
JP5940119B2 (ja)	2016-06-29
LT2271348T (lt)	2018-06-25
HRP20180836T1 (hr)	2018-07-27
WO2009120389A8 (en)	2010-05-14
JP2014221820A (ja)	2014-11-27
KR20110008057A (ko)	2011-01-25
PT3348258T (pt)	2020-11-25

Publication	Publication Date	Title
ZA201008887B (en)	2014-11-26	Oral compositions and uses thereof
IL271132A (en)	2020-01-30	New preparation and dosage
ZA201008090B (en)	2012-08-29	Methods and compositions for oral administration of exenatide
ZA201007920B (en)	2014-10-29	Oral compositions and uses thereof
SG10201403696UA (en)	2014-10-30	Therapeutic compounds and compositions
IL208440A0 (en)	2010-12-30	Oral and injectable formulations of tetracycline compounds
IL206835A0 (en)	2010-12-30	Methods and compositions for oral administration of insulin
PL2173345T3 (pl)	2016-01-29	Doustna formulacja metadoksyny
IL206288A0 (en)	2010-12-30	Novel dosage and formulation
EP2262754A4 (en)	2012-03-14	MINOCYCLINE COMPOUNDS AND METHODS OF USE THEREOF
ZA201107847B (en)	2014-03-26	Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof
PL2285450T3 (pl)	2019-03-29	Kompozycje do higieny jamy ustnej i sposoby
ZA201102446B (en)	2012-07-25	Oral formulation
ZA201103791B (en)	2012-07-25	Oral dosage forms of bendamustine
EP2361087A4 (en)	2012-04-25	INFLAMMATORY COMPOUNDS AND COMPOSITIONS THEREFOR
IL213559A0 (en)	2011-07-31	Oral formulations
ZA201100944B (en)	2012-07-25	Oral formulations of chemotherapeutic agents
GB0902648D0 (en)	2009-04-01	Pharmaceutical compounds and compositions
ZA201204530B (en)	2014-11-26	Oral care compositions and methods
GB0908317D0 (en)	2009-06-24	Pharmaceutical compounds and compositions
HK1152481A (en)	2012-03-02	Oral and injectable formulations of tetracycline compounds
IL208967A0 (en)	2011-01-31	Methods and compositions for oral administration of exenatide
SG10201402363YA (en)	2014-10-30	Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof
GB0903945D0 (en)	2009-04-22	Pharmaceutical compounds and compositions
GB0902651D0 (en)	2009-04-01	Pharmaceutical compounds and compositions